PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27138632-0	2016	[Study on the therapy of castration-resistant prostate cancer : Randomized phase II study of abiraterone acetate with LHRH therapy vs. abiraterone acetate without LHRH therapy in patients with progressive chemotherapy-naive castration-resistant prostate cancer (SPARE) - AP 67/11 of the Association of Urogenital Oncology (AUO)].	Abiraterone Acetate	93-112	gonadotropin releasing hormone 1	Homo sapiens	118-122	
35293700-13	2022	Abiraterone acetate reduced the risks of Alzheimer"s disease and Parkinson"s disease conferred by GnRH agonists, whereas the risk for ALS was reduced by androgen receptor inhibitors.	Abiraterone Acetate	0-19	gonadotropin releasing hormone 1	Homo sapiens	98-102